Pharmaceutical Technology

MARCH 13, 2023

The US Food and Drug Administration (FDA) has granted approval for Acadia Pharmaceuticals ’ Daybue (trofinetide) to treat Rett syndrome in adult and paediatric patients aged two years and above. Acadia Pharmaceuticals CEO Steve Davis said: “Today marks an important milestone for the Rett community and Acadia.

Food and Drug Administration 72

Food and Drug Administration Pharmaceutical FDA Side effects 72

European Pharmaceutical Review

NOVEMBER 7, 2022

Lab-grown blood cells have been transfused into a second patient in the world’s first-of-a-kind clinical trial , opening up future treatments for blood disorders such as sickle cell if found safe and effective. They anticipate patients who need regular blood transfusions could require fewer transfusions over time.

Patients 117

Patients Side effects Manufacturing Medical 117

PM360

JULY 26, 2022

Following the impact of the COVID pandemic in 2020, patient engagement has become the focus area for more than half of healthcare chief information officers (CIOs). At the same time, patient portals have always been considered one of the most efficient tools for patient engagement. Explaining Medication Action.

Pharma 105

Pharma Patients Healthcare Provider Physicians 105

pharmaphorum

JANUARY 31, 2023

Despite this, pharmaceutical companies have not won over public trust. A recent study found that only 48% of participants expressed trust in pharmaceutical companies. This lack of trust in such a crucial industry can lead to decreased compliance, poor treatment adherence, and negative health outcomes for patients.

Patients 52

Patients Pharma Side effects Education 52

Pharmaceutical Technology

NOVEMBER 30, 2022

While patients diagnosed with relapsing MS (RMS) have a wide range of marketed treatment options, patients diagnosed with progressive MS, especially primary progressive MS (PPMS), have very limited treatment options. Currently, only Roche’s Ocrevus (ocrelizumab) is available for this patient population and its efficacy is limited.

Patients 98

Patients Side effects Safety Pharmaceutical 98

Pharma Marketing Network

JULY 19, 2023

Content Marketing as a Sales Driver: Unlocking Your Business Potential in the Pharmaceutical Industry Content marketing is a long-term strategy that can help businesses of all sizes generate leads, increase brand awareness, and drive sales. In the pharmaceutical industry, content marketing can be particularly effective for driving sales.

Marketing 98

Marketing Pharmaceutical Sales Education 98

European Pharmaceutical Review

JUNE 5, 2023

Ninety-four percent of advanced stage (3 or 4) classic Hodgkin lymphoma patients treated with nivolumab, a PD-1 checkpoint inhibitor plus AVD chemotherapy (N-AVD) had one-year progression-free survival (PFS), according to Phase III trial results.

Patients 87

Patients Side effects Healthcare Healthcare 87

Pharmaceutical Technology

MARCH 26, 2024

Learn how this method can reduce chemotherapy side effects and improve patient outcomes. Discover GlycoMimetics Inc.'s s groundbreaking patent for treating cancer and related conditions with Formula (I) compound.

Side effects 59

Side effects Patients 59

Pharmaceutical Technology

JANUARY 12, 2024

The UK nod for Agamree, which comes after previous approvals in Europe and the US, provides access to a corticosteroid with less severe side effects.

Side effects 52

Side effects Patients 52

Eversana Intouch

APRIL 4, 2024

MM+M recently named Teva Pharmaceuticals’ AUSTEDO XR campaign as their Campaign of the Week! AUSTEDO XR helps treat tardive dyskinesia (TD), a side effect of taking medications for mental illness. It’s estimated that some 85% of TD cases go undiagnosed.

Side effects 77

Side effects Healthcare Provider Healthcare Healthcare 77

Rep-Lite

DECEMBER 7, 2023

Getting into pharmaceutical sales and selling pharmaceutical products may require patience and persistence, but for individuals with the right qualifications and a passion for the field, it can be a rewarding and financially lucrative career. What is Pharmaceutical Sales? Why Pursue a Career in Pharmaceutical Sales?

Pharmaceutical Sales 52

Pharmaceutical Sales Pharmaceutical Sales Interpersonal Skills 52

European Pharmaceutical Review

APRIL 5, 2024

These interim data indicate early signs of potential clinical benefit with mRNA-3927, and importantly also demonstrate that mRNA-3927 has infrequent treatment-limiting side effects. The post mRNA therapy could provide intracellular protein replacement for rare disease appeared first on European Pharmaceutical Review.

Side effects 93

Side effects Safety Patients Leads 93

Contrarian Sales Techniques

JANUARY 25, 2023

When I first started working as a pharmaceutical sales representative, I didn't fully understand the importance of product knowledge and accurate information. As a pharmaceutical sales representative, I have received extensive training on the products I represent.

Product Knowledge 52

Product Knowledge Pharmaceutical Sales Sales Pharmaceutical 52

European Pharmaceutical Review

OCTOBER 21, 2022

Clinical trial results presented at the US IDWeek conference, revealed a three-dose series of the HEPLISAV-B vaccine prevents hepatitis B virus (HBV) in HIV patients not previously vaccinated against or infected with the virus. A breakdown of the data showed: HbsAb levels were greater than 1000mIU/ml in 88 percent of patients.

Patients 79

Patients Food and Drug Administration Side effects Food 79

European Pharmaceutical Review

DECEMBER 7, 2022

The common, expected side effects were within expectations for a vaccine in this age group. The post Comirnaty^® authorised for patients six months to four years appeared first on European Pharmaceutical Review. Data that facilitated the line extension of Comirnaty ® for Covid-19.

Food and Drug Administration 89

Food and Drug Administration Patients Side effects Medicine 89

Contrarian Sales Techniques

JUNE 18, 2023

Pharmaceutical sales comprise a dynamic, demanding, and rewarding field. Within it, knowing how to effectively finalize a sale is an invaluable ability that plays a pivotal role in successful pharmaceutical selling techniques. This situation underlines the evolving nature of the pharmaceutical sales field.

Pharmaceutical Sales 52

Pharmaceutical Sales Sales Pharmaceutical Doctors 52

European Pharmaceutical Review

MARCH 25, 2024

“Gram-negative bacteria are often resistant to multiple drugs, leaving infected patients very ill and at high risk of severe complications, including mortality,” said James Rusnak, Senior Vice President and Chief Development Officer, Internal Medicine, Anti-Infectives and Hospital, Pfizer. “If

Side effects 96

Side effects Medicine Safety Patients 96

European Pharmaceutical Review

OCTOBER 9, 2023

A new drug, part of a class of chemicals called potassium-channel openers, has demonstrated potential in offering relief to patients with focal epilepsy. Comparatively, patients given a placebo had on average 18 percent fewer seizures during the treatment phase of the trial, which lasted eight weeks.

Side effects 99

Side effects Recruitment Safety Medicine 99

European Pharmaceutical Review

OCTOBER 31, 2022

The Pharmacovigilance Risk Assessment Committee (PRAC) , the European Medicines Agency (EMA)’s safety board, has confirmed it recommends the withdrawal of Marketing Authorisation Application (MAA) for amfepramone obesity medicines, to prevent more patients being at risk of serious side effects. Risks of amfepramones.

Side effects 87

Side effects Medicine Safety Marketing 87

European Pharmaceutical Review

NOVEMBER 24, 2023

Amgen’s new immunotherapeutic agent Tarlatamab has been shown in a Phase II trial to provide sustained anti-tumour activity in 40 percent of the small cell lung cancer patients. The international DeLLphi-301study was investigated as a new anti-cancer treatment option for patients previously considered to be beyond treatment.

Side effects 110

Side effects Patients Medicine Leads 110

Clarivate

JUNE 26, 2023

Obtaining the preferences of patients and their caregivers is not a new concept in healthcare. Increasingly, however, industry guidance documents utilize the term ‘patient preference’ in relation to new drug development and benefit-risk assessment. Health technology assessment (HTA) bodies also have some appetite for this information.

Food and Drug Administration 52

Food and Drug Administration Patients Side effects Medicine 52

European Pharmaceutical Review

NOVEMBER 1, 2022

The committee advises that Cibinqo (abrocitinib), Jyseleca (filgotinib), Olumiant (baricitinib), Rinvoq (upadacitinib) and Xeljanz (tofacitinib), used for chronic inflammatory conditions, should have limited distribution to minimise risk of serious side effects such as cardiovascular diseases, blood clots, cancer and serious infections.

Side effects 92

Side effects Distribution Safety Patients 92

European Pharmaceutical Review

JULY 5, 2022

The availability of oral chemotherapy treatments would provide stomach cancer patients with the option of more efficacious drugs with improved tolerability in a more convenient dosage format” The poor clinical outcomes of stomach cancer make it a key target for drug development. New hope for stomach cancer patients.

Patients 89

Patients Food and Drug Administration Side effects Safety 89

European Pharmaceutical Review

MARCH 9, 2023

A pilot study has demonstrated that a nasal version of the drug Foralumab, an anti-CD3 monoclonal antibody suppressed the inflammatory T cell response and decreased lung inflammation in patients with COVID-19. Foralumab’s immune modulating response In 2020, Moreira researched how Foralumab modulates the immune response to reduce inflammation.

Side effects 145

Side effects Patients Leads Medical 145

European Pharmaceutical Review

NOVEMBER 16, 2023

It has been conditionally authorised by the UK Medicines and Healthcare products Regulatory Agency (MHRA) as a gene-editing therapy for certain patients 12 years old and over with sickle-cell disease and transfusion-dependent β-thalassemia. Side effects from treatment were similar to those associated with autologous stem cell transplants.

Safety 99

Safety Side effects Medicine Patients 99

Pharmaceutical Technology

JUNE 5, 2023

Results unveiled at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting indicate that some patients with locally advanced rectal cancer can be treated with chemotherapy alone and may not need radiation therapy before surgery. Additionally, the patients had to be candidates for surgery. In the FOLFOX group, 9.1%

Patients 52

Patients Side effects Medicine 52

European Pharmaceutical Review

SEPTEMBER 26, 2022

The GM herpes simplex virus (RP2) successfully treated twenty five percent of patients with different advanced cancers, including skin, oesophageal and head and neck cancers. Their diseases did not respond to the cancer immunotherapy checkpoint inhibitor immunotherapy, so the patients chose to enrol in the Phase I trial.

Side effects 95

Side effects Patients Consulting Medical 95

European Pharmaceutical Review

DECEMBER 22, 2023

It has demonstrated improvements in cognition and is not associated with common side effects of currently approved treatments like weight gain. The drug is also undergoing trials both for adjunctive therapy to existing standard of care agents in schizophrenia and for the treatment of psychosis in patients with Alzheimer’s disease.

Food and Drug Administration 96

Food and Drug Administration Side effects Safety Food 96

European Pharmaceutical Review

NOVEMBER 18, 2022

The product, produced by biopharma company PTC Therapeutics, is approved for patients 18 months and over. Upstaza is administered through a minimally invasive neurosurgical stereotactic procedure used to treat several neurological disorders in paediatric and adult patients. Upstaza clinical trials.

Side effects 126

Side effects Biopharma Safety Patients 126

European Pharmaceutical Review

NOVEMBER 2, 2023

This evidence included comparisons of the products on an analytical level using chemical and biological tests and assays that confirmed similarity in the structural and functional features of Wezlana and Stelara, as well as comparative human pharmacokinetic data, clinical immunogenicity data and other clinical safety and effectiveness data.

Food and Drug Administration 92

Food and Drug Administration FDA Side effects Safety 92

European Pharmaceutical Review

MARCH 8, 2023

If the orally-delivered drug is confirmed have similar in safety and efficiency as the injectable forms, researchers stated that a PCSK9 inhibitor in a pill form could lower costs, increase convenience and expand patient access to the treatment. This is a highly effective compound that was well tolerated,” stated Dr Christie M.

Side effects 91

Side effects Safety Medicine Patients 91

Pharmaceutical Technology

DECEMBER 7, 2022

On 29 November, the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) warned of some new and potentially serious eye-related side effects associated with Dupixent, an interleukin (IL)-4/13 inhibitor drug used in the treatment of numerous allergic indications such as atopic dermatitis, asthma and nasal polyps.

Side effects 64

Side effects Food and Drug Administration Safety Physicians 64

European Pharmaceutical Review

MARCH 14, 2024

Sosei Heptares’ treatment aims to address the significant population of schizophrenia patients who are unresponsive to existing treatments or who cannot tolerate some of the side effects of antipsychotics, Boehringer Ingelheim noted.

Side effects 81

Side effects Sales Pharmaceutical Patients 81

Silver Line CRM

NOVEMBER 11, 2020

Reading time: 7 minutes As we all look to 2021, what are the pharmaceutical industry trends to build into your life sciences marketing strategy? Pharmaceutical, biotech, and life sciences companies bring life-changing medicines to a highly regulated market. 2021 pharmaceutical industry trends — and how you can implement them.

Marketing 52

Marketing Pharmaceutical Side effects Insurance 52

European Pharmaceutical Review

MARCH 30, 2023

Intrathecal (IT) (directly into the spinal fluid) and intravenous (IV) nivolumab (anti-PD-1) immunotherapy was found to be safe and improved survival in a subset of melanoma patients with leptomeningeal disease (LMD). Results of the immunotherapy study Across 25 patients, the median overall survival (OS) was 4.9

Side effects 84

Side effects Patients Medicine Leads 84

European Pharmaceutical Review

NOVEMBER 18, 2022

“Today’s approval of a first-in-class therapy adds an important new treatment option for certain at-risk patients,” remarked Dr John Sharretts, director of the Division of Diabetes, Lipid Disorders, and Obesity in the FDA’s Center for Drug Evaluation and Research. Patients randomly received Tzield or placebo.

Food and Drug Administration 96

Food and Drug Administration FDA Side effects Food 96

European Pharmaceutical Review

NOVEMBER 2, 2022

Researchers at Great Ormond Street Hospital for Children (GOSH) and University College London (UCL) Great Ormond Street Institute of Child Health (UCL GOS ICH) have used “universal” CRISPR-edited cells in humans for the first time to treat B-cell acute lymphoblastic leukaemia (B-ALL) child patients with engineered donor T cells.

Side effects 130

Side effects Engineering Consulting Manufacturing 130